|
Jun 7
|
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
|
|
Jun 6
|
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
|
|
Jun 5
|
AstraZeneca completes Fusion Pharmaceuticals acquisition
|
|
May 12
|
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
|
|
May 10
|
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
|
|
May 10
|
Catalyst's New CEO Has Big Ideas For The Small Biotech
|
|
May 8
|
Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
|
|
May 8
|
Every household should be forced to have a smart meter, says British Gas boss
|
|
May 8
|
AstraZeneca withdraws Covid-19 vaccine, citing low demand
|
|
May 8
|
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
|
|
May 8
|
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
|
|
May 8
|
AstraZeneca pulls its COVID-19 vaccine from the European market
|
|
May 8
|
AstraZeneca to withdraw Covid-19 vaccine globally
|
|
May 8
|
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
|
|
May 8
|
PRESS DIGEST-British Business - May 8
|
|
May 7
|
UPDATE 3-AstraZeneca to withdraw COVID vaccine globally as demand dips
|
|
May 7
|
Q1 2024 FibroGen Inc Earnings Call
|
|
May 7
|
AstraZeneca concludes equity investment in Cellectis
|
|
May 6
|
Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio
|
|
May 6
|
AstraZeneca ups stake in Cellectis in latest cell therapy bet
|